Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Lyrica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lyrica was produced by Pfizer and Eisai.

Vyndaqel a bright spot as Pfizer comes under pressure

Vyndaqel a bright spot as Pfizer comes under pressure

The top line was however dragged down by the onset of generic competition in the US to severe pain drug Lyrica (pregabalin), which plunged to $433m from $1.32bn a year ... Upjohn sales were weak in the quarter, down 16% largely because of the impact of

Pfizer raises forecast following growth of biopharma business

Pfizer raises forecast following growth of biopharma business This was primarily due to volume declines of anti-seizure drug Lyrica (pregabalin), due to multi-source generic competition that began in July 2019 in the US.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain rival to Pfizer’s big-selling Lyrica (pregabalin) brand which brought in $4.7bn last year despite generic competition in some markets. ... Like the original Lyrica formulation Daiichi Sankyo’s drug is dosed twice-daily.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... autonomous. Created in the summer reshuffle, the Established Medicines division

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Nevertheless, the new CEO will undoubtedly consider the M&A market once he takes over in 2019, not least because of impending generic threats to $4bn a year blockbuster Lyrica sales

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics